T1D experience with Tirzepatide, Mounjaro, or Zepbound?

Are there any T1D’s out there who could share experiences using Tirzepatide, Mounjaro, or Zepbound?

I’m particularly interested to know if you’ve noticed any increase in dawn phenomenon or highs after eating or intense exercise.

I ask b/c GIP-agonism by tirzepatide can stimulate glucagon production. That isn’t a major issue in T2D b/c it also stimulates insulin production which inhibits the effects on glucagon. I’m wondering what happens in someone who doesn’t make insulin.

Thanks for sharing!

I used Mounjaro for several months and lost 20 lbs. Of course, my blood sugar was lower, and my A1C went down .3 - .4 over a 3-month period. I also used less insulin, as you eat less. However, I would probably never use it again, as eating became unfun. I would go out to eat and be full after a few bites. Also, I had a lot of stomach aches the first few days after a shot. If you want to eat less but have stomach issues, try it.

Thanks so much for sharing - there’s surprisingly little info out there on this drug in people who don’t make their own insulin. It sounds like it really improved your blood sugar!

Do you think it made for fewer/lower BG spikes overall? I’m considering it for weight loss rather than BG control, but I don’t want to take something that might make BGs more difficult to control.

My Dr actually recommended Mounjaro/Tirzepatide over standard GLP1 drugs b/c it’s supposed to cause less stomach problems. I guess maybe there’s no winning there.

Your blood sugar will be much better controlled purely from eating less food. Your insulin needs will also decrease due to a lack of food intake. If it did not make food so unappealing, I would still be on it. One of my joys in life is eating good food with family and friends. When talking this shot, food was not enjoyable.

Interesting - I think that enjoying food less to some degree might help me to lose weight. I can definitely see that going too far, though. Did you find this to be a problem even at lower doses?